Abstract
Modern-day primary hyperparathyroidism (PHPT) usually presents as mild hypercalcemia and is often asymptomatic. Severe PHPT can present with pathologic fracture related to underlying associated bone disease (osteitis fibrosa cystica) that can often be mistaken for malignancy. Severe, long-standing hypocalcemia with a normal or increased parathyroid hormone (PTH) level, hungry bone syndrome, more commonly occurs after parathyroidectomy in the setting of severe, long-standing PHPT and in the presence of associated bone disease. Treatment with calcium and calcitriol may be required for months following surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485–93.
Wynne AG, et al. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine. 1992;71(4):197–205.
Robert JH, et al. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Ann Surg Oncol. 2005;12(7):526–32.
Yang Q, et al. Skeletal lesions in primary hyperparathyroidism. Am J Med Sci. 2015;349(4):321–7.
Spinelli C, et al. Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology. J Endocrinol Invest. 2000;23(4):255–7.
Witteveen JE, et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol/Eur Fed Endocr Soc. 2013;168(3):R45–53.
Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med. 1988;84(4):654–60.
Lee IT, et al. Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J Bone Miner Metab. 2006;24(3):255–8.
Kumar A, Ralston SH. Bisphosphonates prevent the hungry bone syndrome. Nephron. 1996;74(4):729.
Davenport A, Stearns MP. Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome. Nephrology. 2007;12(4):386–90.
Wirowski D, et al. Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism. Langenbeck’s Arch Surg/Deut Ges Chir. 2013;398(1):131–8.
Meyers MO, et al. Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet. Am Surg. 2009;75(9):843–7.
Conflict of Interest
All authors state that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Mayo Foundation for Medical Education and Research
About this chapter
Cite this chapter
Kearns, A.E. (2016). Severe Primary Hyperparathyroidism. In: Kearns, A., Wermers, R. (eds) Hyperparathyroidism. Springer, Cham. https://doi.org/10.1007/978-3-319-25880-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-25880-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25878-2
Online ISBN: 978-3-319-25880-5
eBook Packages: MedicineMedicine (R0)